UPDATE 1-Swedish bid target Q-Med downbeat on margins

to sustain and raise market share for products within the Restylane product family, an anti-ageing treatment that rivals Allergan Inc's (AGN.N "This will result in higher costs for marketing, sales organization and product development relative to Q-Med's...